And having kidneys from another species that could be delivered in a timely manner for these patients ... 1st new class of schizophrenia drug in more than 3 decades In September, the FDA approved ...

From a pig kidney transplant to restoring genetic deafness, 2024 was a year full of medical breakthroughs. The breakthroughs ...

A new study has identified a unique brain network that links varied patterns of brain atrophy, or shrinkage, associated with schizophrenia. A new study led by investigators from Mass General ...

In the wake of the approval Bristol Myers Squibb’s Cobenfy, it seems that news has ramped up in the schizophrenia space. The latest contender is Reviva Pharmaceuticals’ brilaroxazine ...

Boehringer Ingelheim has taken an option on a family of compounds with potential as therapies for schizophrenia from Sosei Heptares, which it says could have broad activity against the symptoms of ...

How many other heat-related deaths among unhoused residents are being erased by the failure to collect and report accurate ...

Nobel Disease refers to Nobel Prize winners adopting scientifically unsound ideas later in life, often straying from their ...

A new study led by investigators from Mass General Brigham has identified a unique brain network that links varied patterns of brain atrophy, or shrinkage, associated with schizophrenia.

Summary: A new study has identified a distinct brain network connecting areas of atrophy associated with schizophrenia, offering a unified view of its neuroanatomy. By analyzing data from over 90 ...

Schizophrenia is a severe and debilitating psychiatric disorder that involves psychotic symptoms such as hallucinations and delusions, accompanied with regressive behaviour. Circuit and cell type ...

Bristol-Myers Squibb's $14 billion bet on buying Karuna Therapeutics looks set to pay off after it got FDA approval for the schizophrenia drug at the heart of the deal. The US regulator has ...